Skip to main content

Table 1 VHL peptides used for vaccinations (corresponding mutant part of peptide underlined)

From: A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic Renal Cell Carcinoma

Patient

Mutant VHL peptide

1

YHTASVYSERAM

2

CLQVARSLVK

3

PGTGRRIHIYRGHLWL

4

RRIHSYRGDLWLFRDA

5

MEAGRPRPCCAR

6

RLALQRCRDTRWA

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us